HYPERION THERAPEUTICS INC 4
4 · HYPERION THERAPEUTICS INC · Filed May 8, 2015
Insider Transaction Report
Form 4
Nash Christine A
SVP & Chief Commercial Officer
Transactions
- Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−59,087$2,718,002→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07−18→ 0 totalExercise: $327.95Exp: 2018-04-21→ Common Stock (18 underlying) - Disposition from Tender
Common Stock
2015-05-07$46.00/sh−11,503$529,138→ 0 total - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−25,500$1,173,000→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−50,000$2,300,000→ 0 totalExercise: $26.74Exp: 2024-03-10→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−32,500$1,495,000→ 0 totalExercise: $25.97Exp: 2025-02-08→ Common Stock (32,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07−91→ 0 totalExercise: $327.95Exp: 2017-08-30→ Common Stock (91 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−6,881$316,526→ 0 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (6,881 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−39,500$1,817,000→ 0 totalExercise: $24.46Exp: 2023-04-14→ Common Stock (39,500 underlying)
Footnotes (5)
- [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
- [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
- [F3]Shares that are being acquired by Horizon in the Merger.
- [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
- [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.